liver
FDA approves drug for primary biliary cholangitis
August 15, 2024Research and Development FDA Approval, FDA approva;, Hepatology, liver, primary biliary cholangitis
Accelerated approval has been granted for Gilead Science’s Livdelzi (seladelpar) to treat primary biliary cholangitis (PBC) by the US Food …
Eli Lilly shares results for tirzepatide for MASH resolution
June 10, 2024Research and Development Eli Lilly, Hepatology, MASH, clinical trial, liver
Eli Lilly has announced results from the phase 2 SYNERGY-NASH study which assessed 190 patients, with or without type 2 …
Pfizer and Novartis partner up to develop combo therapies for NASH
October 29, 2018Research and Development, Sales and Marketing Novartis, Pfizer, liver, nash, pharma
Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or …
Regenerative process could be restored in liver after severe injuries, study shows
August 16, 2018Research and Development Edinburgh University, liver, mice, research, transplants
Scientists at the University of Edinburgh were able to restore a regenerative response that prevented the need for a liver …
Research unveils new drug targets for more effective treatment of liver disease
August 22, 2017Manufacturing and Production, Research and Development life sciences, liver, liver cancer, liver disease, pharma, pharmaceuticals
Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …
Gilead presents data highlighting progress and efficacy in liver and hepatitis C therapies
April 20, 2016Research and Development, Sales and Marketing Gilead, harvoni, hepatitis, liver, sofosbuvir
Gilead (NASDAQ: GILD) has presented a broad range of results on its current and potential therapeutics at the International Liver …
Engineers create lab-grown heart and liver tissue for drug testing and discovery
March 10, 2016Manufacturing and Production, Research and Development 3D, angiochip, artificial heart, drug delivery, innovation, liver, vessels
Researchers at University of Toronto have developed “person-on-a-chip” technology which sees the growing of realistic human tissues outside the body. …
Gilead acquires Phenex liver disease drugs
January 7, 2015Research and Development, Sales and Marketing Farnesoid X Receptor, Gilead, liver, nafld, nash, phenex
Gilead Sciences has acquired Phenex Pharmaceuticals’ development programme for the treatment of serious liver diseases. The US biopharma firm will …
GE and Takeda make liver pact
November 13, 2014Research and Development, Sales and Marketing GE Healthcare, Japan, Takeda, US, liver, nafld, nash
GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …
BMS claims advance with hepatitis C regimen
November 10, 2014Research and Development, Sales and Marketing BMS, Gilead, HCV, dcv-trio, hep C, hepatitis C, liver, sovaldi
Bristol-Myers Squibb has reported data for its hepatitis C virus cocktail that it says outperforms even newer all-oral therapies in …
Late-stage failure for Afinitor
August 8, 2013Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver
Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
